Treatment or prevention of diseases and disorders associated with cells that express IL-6… Grant US-11827700-B2 United States of America 28 Nov 2023
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF Application WO-2023138770-A1 World Intellectual Property Organisation (WIPO) 27 Jul 2023
EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3… Application WO-2023091988-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
UNIVERSAL SARBECOVIRUS VACCINES Application WO-2023088968-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application WO-2023031437-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
METHODS AND KIT FOR DETERMINING THE ANTIBODY STATUS AND T-CELL IMMUNITY AGAINST SARS-COV-2 Application EP-4145132-A1 European Patent Office 08 Mar 2023
INDUCTION OF IMMUNITY TO SARS-COV-2 IN CHILDREN Application WO-2022197209-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155524-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
VARIANT STRAIN-BASED CORONAVIRUS VACCINES Application WO-2022155530-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
ANTIBODIES CONJUGATED OR FUSED TO THE RECEPTOR-BINDING DOMAIN OF THE SARS-COV-2 SPIKE… Application WO-2022101302-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED… Application WO-2021188727-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021